Cargando…
The Response of Hemostatic Marker Levels to Activated Factor VII in a Neonate following Cardiopulmonary Bypass
The primary function of recombinant activated factor VII (rFVIIa) is to increase thrombin formation which leads to increased fibrin and less “bleeding.” As a result, most of literature utilizes “bleeding” as the outcome measure with respect to rFVIIa. However, we report the actual effect of rFVIIa o...
Autores principales: | Eisses, Michael J., Richards, Michael, Joffe, Denise, Geiduschek, Jeremy M., Chandler, Wayne L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2735071/ https://www.ncbi.nlm.nih.gov/pubmed/19730751 http://dx.doi.org/10.1155/2009/420152 |
Ejemplares similares
-
The Use of Hemostatic Blood Products in Children Following Cardiopulmonary Bypass and Associated Outcomes
por: Closson, Ryan, et al.
Publicado: (2020) -
Hemostatic Challenges in Neonates
por: Davenport, Patricia, et al.
Publicado: (2021) -
Population Pharmacokinetic/Pharmacodynamic Modeling of Methylprednisolone in Neonates Undergoing Cardiopulmonary Bypass
por: Hornik, Christoph P., et al.
Publicado: (2019) -
Massive Rhabdomyolysis Following Cardiopulmonary Bypass
por: Kim, Young Sam, et al.
Publicado: (2014) -
Coagulation and neonatal bypass: an assessment of changes in coagulation factor concentration during cardiopulmonary bypass in neonates, with modified ultrafiltration
por: Arnold, P, et al.
Publicado: (1999)